Penny stock to watch today is VYCO.
Vycor Medical, Inc. is a medical device company committed to making neurological brain, spinal and other surgical procedures safer and more effective. Vycor's innovative medical instruments are designed to optimize neurosurgical site access, reduce patient risk, accelerate recovery, and add tangible value to the professional medical community. (vycormedical.com)
After news released yesterday,Vycor Medical, Inc. ("Vycor") (OTCBB: VYCO) today announces that Richard P. Denness will be joining Vycor as its new Chief Executive Officer, replacing Ken Coviello. During this transition period, Ken will retain a role with the company on a consultancy basis.
Since the acquisitions of NovaVision, Inc. and Sight Science Limited, Vycor has become an international group of greater complexity with several businesses. Richard Denness is a healthcare executive with global experience who has held senior management positions at UCB, Inc., Schwarz Pharma US, Schering-Plough and IVAX Corporation (vycormedical.com). it should be the right time for this stock to start making benefits for its traders.
We have seen the volume comes up and above the volume average.
barchart.com
It's 40% buy at this time. This number should go higher when the market is open.
I advise you to do your own research before trading with any stock.
Good luck!
Vycor Medical, Inc. is a medical device company committed to making neurological brain, spinal and other surgical procedures safer and more effective. Vycor's innovative medical instruments are designed to optimize neurosurgical site access, reduce patient risk, accelerate recovery, and add tangible value to the professional medical community. (vycormedical.com)
After news released yesterday,Vycor Medical, Inc. ("Vycor") (OTCBB: VYCO) today announces that Richard P. Denness will be joining Vycor as its new Chief Executive Officer, replacing Ken Coviello. During this transition period, Ken will retain a role with the company on a consultancy basis.
Since the acquisitions of NovaVision, Inc. and Sight Science Limited, Vycor has become an international group of greater complexity with several businesses. Richard Denness is a healthcare executive with global experience who has held senior management positions at UCB, Inc., Schwarz Pharma US, Schering-Plough and IVAX Corporation (vycormedical.com). it should be the right time for this stock to start making benefits for its traders.
We have seen the volume comes up and above the volume average.
barchart.com
It's 40% buy at this time. This number should go higher when the market is open.
I advise you to do your own research before trading with any stock.
Good luck!
No comments:
Post a Comment